Cassava Sciences Inc. sell stratec
Start price
27.06.18
/
50%
€1.95
Target price
02.07.18
€1.53
Performance (%)
-4.63%
End price
02.07.18
€1.86
Summary
This prediction ended on 02.07.18 with a price of €1.86. With a performance of -4.63%, the SELL prediction by stratec was trending in the right direction. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cassava Sciences Inc. | -14.715% | -14.715% | -60.576% | -95.730% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by stratec for this prediction
In the thread Cassava Sciences Inc. diskutieren
stratec stimmt dem Sentiment von 'Buy' nicht zu
stratec stimmt am 27.06.2018 dem Buy-Gesamtsentiment mit dem Kursziel 9.0$ nicht zu.
- A joint FDA panel has voted against approval for Pain Therapeutics Remoxy ER treatment.
(Vom Mitglied beendet)